NEW YORK, March 26, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of MiMedx Group Inc. ("MiMedx") (NASDAQ:MDXG) between March 7, 2013 and February 21, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. To get more information go to:
http://www.zlk.com/pslra-d/mimedx-group-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) MiMedx was engaged in a “channel-stuffing” scheme designed to inappropriately recognize revenue that had not yet been realized; (ii) the Company lacked adequate internal controls over financial reporting; and (iii) that as a result of the foregoing, MiMedx’s publicly disseminated financial statements were materially false and misleading.
On February 20, 2018, MiMedx announced that it would postpone the release of its financial results and Form 10-K filing for 2017. MiMedx stated it had engaged “independent legal and accounting advisors to conduct an internal investigation into current and prior-period matters relating to the allegations regarding certain sales and distribution practices at the Company.” Following this news, shares of MiMedx fell from a close of $14.47 per share on February 16, 2018 to a close of $8.75 on February 20, 2018.
If you suffered a loss in MiMedx you have until April 25, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Telegram Restored on Apple App Store After Temporary Removal
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Jetstar to Charge for Overhead Cabin Bags From February
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 



